(Q41568393)

English

Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study

scientific article published on 20 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 October 2017

Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study (English)

1 reference

Europe PubMed Central

3 October 2017

0 references

Cosimo De Nunzio

4

1 reference

Europe PubMed Central

3 October 2017

1

object named as

Mauro Gacci

0 references

Giovanni Corona

7

object named as

Giovanni Corona

1 reference

Europe PubMed Central

3 October 2017

10

object named as

Mario Maggi

1 reference

Europe PubMed Central

3 October 2017

Steven A Kaplan

9

object named as

Steven A Kaplan

1 reference

Europe PubMed Central

3 October 2017

6

object named as

Linda Vignozzi

1 reference

Europe PubMed Central

3 October 2017

12

object named as

Sergio Serni

1 reference

Europe PubMed Central

3 October 2017

5

object named as

Andrea Tubaro

1 reference

Europe PubMed Central

3 October 2017

Arcangelo Sebastianelli

2

object named as

Arcangelo Sebastianelli

1 reference

Europe PubMed Central

3 October 2017

8

object named as

Kevin T McVary

1 reference

Europe PubMed Central

3 October 2017

author name string

Matteo Salvi

3

1 reference

Europe PubMed Central

3 October 2017

Marco Carini

11

1 reference

Europe PubMed Central

3 October 2017

publication date

20 April 2015

1 reference

Europe PubMed Central

3 October 2017

BJU International

1 reference

Europe PubMed Central

3 October 2017

116

1 reference

Europe PubMed Central

3 October 2017

2

1 reference

Europe PubMed Central

3 October 2017

271-277

1 reference

Europe PubMed Central

3 October 2017

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Correlation between benign prostatic hyperplasia and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

The correlation between metabolic syndrome and prostatic diseases

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: a role for GPR30/GPER?

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Benign prostatic hyperplasia: a new metabolic disease?

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FBJU.13038

21 January 2018

Identifiers

10.1111/BJU.13038

1 reference

Europe PubMed Central

3 October 2017

1 reference

Europe PubMed Central

3 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41568393&oldid=1924572637"